Pharmacological Treatment of H. Pylori Related Peptic Ulcer Disease

This course explores Helicobacter pylori (H. pylori)-related peptic ulcer disease, covering its symptoms, etiology, and the underlying pathophysiology of gastric and duodenal ulcers. Participants will gain a comprehensive understanding of patient evaluation, diagnosis, and evidence-based treatment approaches, including both pharmacologic and nonpharmacologic strategies.

The course discusses pharmacologic therapies such as antacids, H2 receptor antagonists, proton pump inhibitors (PPIs), sucralfate, antibiotics for H. pylori eradication, and misoprostol, as well as patient education strategies to enhance treatment adherence and prevent recurrence. By the end of the course, learners will be equipped with the knowledge to manage peptic ulcer disease and optimize patient outcomes effectively

Completion Requirements:

To receive full CE credit for this course, participants must:

• Be registered for the course.
• Review all course material.
• Complete the post-test with a passing score of 70% or higher.
• Submit the course evaluation survey.

Note: Some courses may also require participation in discussion boards, practice exercises, or additional learning activities.

Important Disclosures:

• Conflict of Interest: he planners, authors, and presenters have disclosed no conflicts of interest or financial relationships with any commercial entities related to this activity.
• Commercial Support: This CE activity is not commercially sponsored.
• Non-Endorsement: AApproval of this CE course applies only to its educational content and does not imply endorsement of any specific product, service, or company.
• Off-Label Product Use: This course excludes unapproved or off-label product usage information.